CDKN2B-AS1 and medulloblastoma: For instance, NKX2-2AS has been shown to suppress tumorigenesis in SHH-driven medulloblastoma [16], while HHIP-AS1, TP73-AS1, CCAT1, CRNDE, LOXL1-AS1, ANRIL, and linc-NeD125 have been reported to promote medulloblastoma cell proliferation and migration [17–23].